Review
Accepted on 15 Apr 2025
Inhibition of NMDA receptors and other ion channel types by membrane-associated drugs
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1561956
Type at least 3 characters
533 articles
Original Research
Accepted on 10 Apr 2025
Early Reduction of Skin Potassium without Sodium Accumulation in the Pathogenesis of Salt Sensitivity in Primary Aldosteronism
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1575972
- 100 views
Original Research
Published on 10 Apr 2025
The venom of Cyriopagopus schmidti spider contains a natural huwentoxin-IV analogue with unexpected improved analgesic potential
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1566312
- 278 views
Original Research
Accepted on 31 Mar 2025
Gaussian white noise stimulation as an alternative method to excite sensory neurons
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1561905
Review
Published on 28 Mar 2025
Role of voltage-gated chloride channels in epilepsy: current insights and future directions
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1560392
- 438 views
Review
Published on 26 Mar 2025
Sodium channels as a new target for pain treatment
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1573254
- 954 views
Review
Published on 24 Mar 2025
Mechanisms mediating effects of cardiotonic steroids in mammalian blood cells
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1520927
- 567 views
Opinion
Published on 21 Mar 2025
When HERG-caused LQT2 encounters antisense oligonucleotide: is exon 6 skipping therapy plausible?
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1535259
- 477 views
Review
Published on 21 Mar 2025
Recent insights on the impact of SWELL1 on metabolic syndromes
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1552176
- 631 views
Original Research
Published on 07 Mar 2025
Selenium reduces oxaliplatin induced neuropathic pain: focus on TRPV1
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1549190
- 981 views
Original Research
Published on 28 Feb 2025
Administration of the KCa channel activator SKA-31 improves endothelial function in the aorta of atherosclerosis-prone mice
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1545050
- 838 views
Original Research
Published on 24 Feb 2025
Intestinal current measurement detects age-dependent differences in CFTR function in rectal epithelium
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1537095
- 979 views
Review
Published on 30 Jan 2025
The enigmatic SLC26A6 multifunctional anion transporter: recent advances in structure-function relationship, pathophysiological significance and novel pharmacological inhibitors
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1536864
- 1,073 views
Original Research
Published on 06 Jan 2025
pH-induced conformational changes in the selectivity filter of a potassium channel lead to alterations in its selectivity and permeation properties
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1499383
- 626 views
Original Research
Published on 18 Nov 2024
Pharmacological rescue of the G85E CFTR variant by preclinical and approved modulators
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1494327
- 1,236 views
- 1 citation
Original Research
Published on 14 Oct 2024
GABA Type A receptors expressed in triple negative breast cancer cells mediate chloride ion flux
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1449256
- 1,454 views